Richter Announces Withdrawal of its Marketing Authorisation Application for Efgratin (biosimilar pegfilgrastim)
2/1/2019
Business related Regulatory Marketing authorization application withdrawn Biotechnology PRODUCT - EFGRATIN API - PEGFILGRASTIM